Ondansetron (Zofran): What Is It Used For?

What is ondansetron?

Ondansetron is a medicine used to help prevent or treat nausea and vomiting. The original content describes it as being used mainly for nausea and vomiting caused by chemotherapy and after surgery.

In the United States, it is known by brand names including Zofran, Zofran ODT, and Zuplenz.

The active ingredient is listed as ondansetron hydrochloride or ondansetron hydrochloride dihydrate.

How ondansetron works

Ondansetron is described as a selective 5-HT3 receptor antagonist. In simple terms, it blocks signals involved in nausea and vomiting in the body and brain.

Uses and therapeutic indications

According to the original content, ondansetron is used for the following:

• Adults: control of nausea and vomiting caused by chemotherapy and cytotoxic radiotherapy, and prevention or treatment of postoperative nausea and vomiting.
• Children 6 months and older: treatment of nausea and vomiting caused by chemotherapy.
• Children 1 month and older: prevention and treatment of postoperative nausea and vomiting with injectable forms.

Dosage information

The original content includes several dosing schedules based on age, weight, body surface area, and the reason for use. Because exact dosing must be individualized, this article does not replace the official prescribing information.

What to verify with a healthcare professional or the official leaflet:

• Which form is being used: oral tablet, orally disintegrating tablet, oral solution, or injection.
• Whether the dose is for chemotherapy-related nausea, radiotherapy-related nausea, or postoperative nausea and vomiting.
• Whether age, weight, body surface area, or liver function changes the dose.
• Whether any other medicines increase the risk of QT prolongation or serotonin syndrome.

Administration notes

The original content states that orally disintegrating tablets are placed on the upper part of the tongue. Follow the instructions on the package or the official leaflet for the exact product you have.

Contraindications

The original content lists the following contraindications:

• Hypersensitivity to ondansetron or other 5-HT3 antagonists.
• Concomitant use with apomorphine.

Warnings and precautions

Ondansetron requires caution in several situations. The original content highlights the following points:

• Limited experience in older adults for prevention and treatment of postoperative nausea and vomiting.
• Use caution in people with congenital prolonged QT syndrome.
• Use caution in people who may develop QT prolongation, including those with electrolyte abnormalities, heart failure, bradyarrhythmias, or other medicines that prolong the QT interval.
• Correct low potassium or low magnesium before treatment when relevant.
• There is a risk of serotonin syndrome when used with other serotonergic medicines such as SSRIs or SNRIs.
• It may mask occult bleeding in patients undergoing adenotonsillar surgery, so monitoring may be needed.
• People with signs of subacute bowel obstruction may need monitoring after administration.
• In children receiving chemotherapy with hepatotoxic agents, liver function monitoring may be needed.
• There are no data in the original content for delayed or prolonged chemotherapy-induced nausea and vomiting in children, or nausea and vomiting caused by radiotherapy in children.

Liver failure

The original content states that ondansetron should be used with caution in moderate to severe liver failure, with a maximum of 8 mg per day.

Drug interactions

Important interactions listed in the original content include:

If you take prescription medicines, over-the-counter products, or herbal supplements, a pharmacist can help check for interactions.

Pregnancy and breastfeeding

The original content says ondansetron is not recommended in pregnancy because safety in human pregnancy has not been established.

It also states that ondansetron passes into milk in lactating animals and that breastfeeding is not recommended while taking it.

Because pregnancy and breastfeeding decisions are highly individual, the official leaflet and a healthcare professional should be consulted for personal guidance.

Effects on driving and machinery

The original content reports that ondansetron does not affect the ability to drive or use machinery and does not cause sedation in psychomotor testing.

Even so, if you feel unwell, dizzy, or otherwise affected, avoid driving until you are sure you can do so safely.

Possible adverse reactions

The original content lists the following side effects:

• Headache
• Hot flashes
• Constipation
• Local reactions at the intravenous injection site

Seek medical advice promptly if you notice severe symptoms, signs of an allergic reaction, palpitations, fainting, or symptoms that worry you.

What to check in the official leaflet

Before using ondansetron, it is sensible to confirm the following in the official patient information or with a pharmacist:

• The exact product form and strength.
• The reason it was prescribed.
• Whether your age group has specific dosing instructions.
• Whether liver problems change the dose.
• Whether your other medicines raise the risk of QT prolongation or serotonin syndrome.

Safety reminder

Frequently asked questions

Sources and reference links

The following resources were included in the original content and may help readers verify product information:

• FDA Medication Guide database
• UNII: 4AF302ESOS
• ChemIDplus
• DrugPortal
• PubChem CID: 4595
• NCI Thesaurus: C1119